| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |